GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by DanielBoone733on Jan 20, 2017 10:06pm

165 Views

Post# 25736467

Don't even need the recreational market!

Health Canada predicts that the total number of patients in the ACMPR or successor programs will reach 450,000 by 2024. However, the market growth trajectory is currently surpassing Health Canada expectations aided more recently by the introduction of medical cannabis oils. The historical growth trends indicates a market potential in excess of 1,000,000 over the same time frame.

To the Company’s knowledge, it is the only licensed producer that meets GMP manufacturing standards (as overseen by regulatory agencies in Canada and elsewhere) for cannabis products. These are the same standards and procedures that pharmaceutical companies must adhere to in manufacturing their products in North America. This provides CanniMed with a unique competitive advantage that may become particularly relevant if new distribution channels are introduced such as pharmacies. Worth noting, even though CanniMed does not yet have GMP certification for the production of its medical cannabis oils, it does adhere to GMP in its production and expects to complete the compliance process within the first half of 2017.

CanniMed will soon introduce the world’s first pharmaceutical-grade cannabis gelcaps. Gelcaps are ideally suited for baby boomers looking for a safe, reliable way to manage their chronic pain smptoms and maintain an active lifestyle. The launch is targeted for early 2017 and will provide further growth and new market opportunities. These are higher margin, value-added products with broader market appeal.

Very exciting things to come!!